SE
Septerna, Inc. (SEPN)
NASDAQ·Healthcare·Biotechnology
$24.19
-3.59%
Mkt Cap $1.12B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $18.20M | $24.12M | +32.52% | -$0.23 | -$0.24 | -4.35% | — | — |
| Q4 2025 Nov 10, 2025 | $17.27M | $21.50M | +24.49% | $0.19 | -$0.09 | -147.37% | — | — |
| Q3 2025 Aug 11, 2025 | $5.00M | $119.00K | -97.62% | -$0.05 | -$0.56 | -1020.00% | — | — |
| Q2 2025 May 15, 2025 | $30.00M | $219.00K | -99.27% | -$0.38 | -$0.49 | -28.95% | — | — |
| Q1 2025 Mar 27, 2025 | — | $212.00K | — | -$0.69 | -$0.64 | +7.25% | — | — |
| Q4 2024 Nov 21, 2024 | — | $176.00K | — | -$0.83 | -$8.40 | -912.05% | — | — |
| Q4 2023 Dec 31, 2023 | — | $118.00K | — | — | $2.05 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | $33.00K | — | — | -$0.56 | — | — | — |